T. Rowe Price Investment Management’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Hold |
2,103,029
| – | – | ﹤0.01% | 613 |
|
|
2025
Q1 | $2.1M | Sell |
2,103,029
-2,899,770
| -58% | -$2.9M | ﹤0.01% | 602 |
|
|
2024
Q4 | $53M | Sell |
5,002,799
-225,534
| -4% | -$2.39M | 0.03% | 402 |
|
|
2024
Q3 | $69.1M | Buy |
5,228,333
+127,237
| +2% | +$1.68M | 0.04% | 356 |
|
|
2024
Q2 | $50.1M | Buy |
5,101,096
+1,517,092
| +42% | +$14.9M | 0.03% | 387 |
|
|
2024
Q1 | $49.3M | Buy |
+3,584,004
| New | +$49.3M | 0.03% | 398 |
|